X
RDY icon

Xponance’s Dr. Reddy's Laboratories RDY Stock Holding History

Xponance’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$283K Buy
19,531
+1,510
+8% +$20.4K ﹤0.01% 1429
2026
Q1 		$250K Buy
18,021
+4,868
+37% +$67.8K ﹤0.01% 1368
2025
Q4 		$185K Sell
13,153
-70
-0.5% -$982 ﹤0.01% 1405
2025
Q3 		$185K Sell
13,223
-2,690
-17% -$38.7K ﹤0.01% 1375
2025
Q2 		$239K Buy
15,913
+3,817
+32% +$54.5K ﹤0.01% 1240
2025
Q1 		$160K Buy
+12,096
New +$167K ﹤0.01% 1297

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Xponance's RDY Position: Q2 2026 in Review

Xponance increased its Dr. Reddy's Laboratories (RDY) stake by 8.4% in Q2 2026, buying an estimated $20.4K and bringing the position to 19,531 shares worth $283K. The position accounts for ﹤0.01% of the portfolio, ranked #1429.

Xponance first reported a position in RDY in Q1 2025 and has held it in 6 quarters since. 239 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Xponance held 19,531 shares of Dr. Reddy's Laboratories worth $283K as of Q2 2026.
  • Xponance bought 1,510 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $20.4K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1429 holding.
  • Xponance first reported a position in Dr. Reddy's Laboratories in Q1 2025 and has held it in 6 quarters since.
  • 239 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.